The clinical development life cycle has become increasingly complex and challenging scientifically while remaining inefficient and costly. The financial commitment needed to bring drug products to market continues to soar. It is crucial to develop technology solutions that work together and increase the speed and quality of the clinical trial process so that better answers about the safety and efficacy of investigational and marketed products are available to sponsors, agencies, investigators and the public more rapidly. With electronic healthcare just around the corner, industry faces increasing pressure to adopt enabling technology to optimize and accelerate drug development. But which technology, which tools, what initiatives are the most important ones to keep on your radar screen?

If you are struggling with these questions, this conference is for you!
•What technology and standards development initiatives are most critical to the biopharmaceutical industry and why?
•How can you leverage some of the work underway in government agencies and standards-setting organizations and when? Which will have the most impact on our industry?
•What information do you need to set priorities now, plan for future developments, and ensure quality and compliance?

The information presented at this conference will help your organization compete….